Biotech Hot Stocks in Focus – GILD, CLSN, DNDN, ARNA
Houston, TX – February 1st, 2013 — (Net PR News) – AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s Stocks in focus are: NASDAQ:GILD, NASDAQ:CLSN, NASDAQ:DNDN, NASDAQ:ARNA
Gilead Sciences, Inc. (NASDAQ:GILD) revealed that, on Monday, February 4, at 4:05 p.m. Eastern Time, it will release its financial results for the fourth quarter and year end 2012. To discuss the fourth quarter and full year 2012 financial results of the company and to provide a financial guidance for 2013 & general business update, the company’s management will host a conference call at 4:30 p.m. Eastern Time. This conference call will be available through the internet.
Gilead Sciences, Inc. percentage change decreased -1.00% to close at $39.45 with the total traded volume of 7.96 million shares, as compared to average volume of 8.54 million shares.
Is GILD A Solid Investment At These Levels? Find Out Exactly Where GILD Is Headed With This TREND ANALYSIS REPORT
The Company’s lowest price during last trade was $39.24, while its highest price was $39.82 for the day. GILD’s total market capitalization is $59.78 billion, along with 1.52 billion shares outstanding. Its beta value stands at 0.44 points and its earning per share remained $1.60.
Celsion Corporation (NASDAQ:CLSN) reported a plunge of -81.17% after opening at the price of $1.59. Its closing price for the day was $1.51.
CLSN’s total trading volume for the day was 42.16 million shares, versus its average volume of 2.47 million shares. The Company’s current market capitalization stands at $52.87 million along with 35.01 million shares.
Get A Free Report And Detailed Analysis On CLSN CLICK HERE To Read
Celsion’s earnings per share is $-0.76, while its beta value stands at 1.19 times. If we look at the previous 5 day’s performance of the stock, it remained decreasing with the loss of -78.43% and, in its last one month’s trade it plunged -81.56%.
Dendreon Corporation (NASDAQ:DNDN) reported that it will review its financial results for the fourth quarter and full year 2012 on Monday, February 25, 2012, at 9:00 a.m. ET. The company’s management will host a conference call.
Dendreon Corporation percentage change decreased-1.51%, to close at $5.88 with the total traded volume of4.96 million shares, as compared to average volume of 7.41 million.
How Should Investors React To DNDN Now? Find Out In This TREND ANALYSIS REPORT
Its market capitalization is $907.38 million and EPS was $-2.13. DNDN’s shares were trading within the range of $5.78-$5.98, while its opening price was $5.90. If we look at its previous three months trade, it surged 54.74%, while in the last 5 day’s it remained down -6.67%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported the increase of 4.32% and closed at $8.45 with the total traded volume of 10.27 million shares. The stock’s opening price was $8.01. The company has a total of 217.29 million outstanding shares and its total market capitalization is $1.84 billion.
The 52-week price range of the stock remained $1.70 – $13.50, while during last trade its minimum price was $8.00 and it gained its highest price of $8.65. The Company’s last 5 days shows a downtrend of -13.51%.
How Should Investors Trade ARNA Now? Don’t Trade ARNA Until You Read This TREND ANALYSIS REPORT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.